EP2982372
Glútamatmótandi lyf til að meðhöndla geðraskanir
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.4.2006EP published:
5.8.2020EP application number:
15182562.7
EP translation filed:
21.9.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
4.4.2026Expiry date:
4.4.2026
Title:
GLUTAMATE MODULATING AGENTS IN THE TREATMENT OF MENTAL DISORDERS
Timeline
Today
5.4.2006EP application
5.8.2020EP Publication
21.9.2020Translation submitted
15.10.2020Registration published
4.4.2026Expires
Owner
Name:
Yale UniversityAddress:
Office of Cooperative Research, 433 Temple Street, New Haven, CT 06511, US
Inventor
Name:
CORIC, VladmirAddress:
Madison, CT Connecticut 06443, US
Name:
KRYSTAL, John H.Address:
Woodbridge, CT Connecticut 06525, US
Name:
SANACORA, GerardAddress:
Guilford, CT Connecticut 06437, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
668735 PDate:
5.4.2005Country:
US
Number:
669774 PDate:
7.4.2005Country:
US
Number:
690187 PDate:
13.6.2005Country:
US
Number:
694621 PDate:
27.6.2005Country:
US
Number:
756472 PDate:
4.1.2006Country:
US
Classification
Categories:
A61K 31/42, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 16
Paid: 18.3.2021
Expires: 4.4.2022
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 21.3.2022
Expires: 4.4.2023
Payer: Patice ehf.
Number: 18
Paid: 21.3.2023
Expires: 4.4.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 19.3.2024
Expires: 4.4.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 2.4.2025
Expires: 4.4.2026
Payer: Árnason Faktor ehf.